TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04919395

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clip device for Nexplanon Removal
Description: The clip device will be used to assist in the removal procedure to remove the Nexplanon implant from the subject.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care procedure
Description: The participants Nexplanon will be removed per standard of care.
Study: NCT06673368

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NRCT-101SR, NRCT-202XR
Description: NRCT-101SR in combination with NRCT-202XR or NRCT-202XR alone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NRCT-101SR, NRCT-202XR
Description: NRCT-101SR in combination with NRCT-202XR or NRCT-202XR alone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NRCT-101SR, NRCT-202XR
Description: NRCT-101SR in combination with NRCT-202XR or NRCT-202XR alone
Study: NCT06362291

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MRI-AI guided cognitive prostate targeted biopsy
Description: Before prostate biopsy, the MR images of patients in the AI-cTB group were uploaded to the AI software. Then the images with suspicious lesions highlighted by AI software were viewed by urologists. Biopsies were performed under the guidance of TRUS through the transrectal or transperineal route.
Study: NCT06777511

Intervention type: DRUG
Intervention: 5-aminolevulinic acid (5-ALA)
Description: All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device as part of their standard stoma management.
Study: NCT06362291

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Routine cognitive prostate targeted biopsy
Description: Before prostate biopsy, the MR images and reports were viewed by urologists preceding the biopsy. Biopsies were performed under the guidance of TRUS through the transrectal or transperineal route.
Study: NCT06622226

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-7018
Description: ONO-7018 tablet(s) are administered orally.
Study: NCT06697106

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs
Description: Patients will undergo direct vision internal urethrotomy (DVIU) plus nonsteroidal anti-inflammatory drugs (NSAID) for 3 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will undergo direct vision internal urethrotomy (DVIU) plus a placebo for 3 weeks.
Study: NCT06698744

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UF-KURE-BCMA CAR T-cells
Description: Experimental anti-BCMA CAR T-cells manufactured with a proprietary ultrafast process. Patients will receive a single dose of CAR T-cells at one of three potential doses:~* Dose -1: 3x10\^6 cells~* Dose 1: 10x10\^6 cells~* Dose 2: 15x10\^6 cells
Study: NCT06777511

Intervention type: DEVICE
Intervention: Photodynamic therapy (PDT)
Description: All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device photodynamic therapy device as part of their standard stoma management.
Study: NCT06778525

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Personalized neuromuscular exercises, according to the patient's specific needs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Personalized neuromuscular exercises, according to the patient's specific needs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SmartPose
Description: Virtual reality application containing rehabilitative games developed for individuals in need of exercise.
Study: NCT06778642

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus Posterior Superior Intercostal Plane Block
Description: Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS) will receive either a Serratus Posterior Superior Intercostal Plane Block (SPSIPB) with bupivacaine after induction and before the surgical procedure begins.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus Anterior Plane Block
Description: Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS) will receive either a Serratus Anterior Plane Block (SAPB) with bupivacaine after induction and before the surgical procedure begins.
Study: NCT06778785

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Intervention
Description: game-based digital intervention app

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Intervention
Description: game-based digital intervention app

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health Education
Description: traditional health education app
Study: NCT05353218

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intermediate cervical plexus block
Description: Intermediate cervical plexus block will be applied in transverse plane using posterior approach at C4.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Deep cervical plexus block
Description: Deep cervical plexus block will be appliedin transverse plane using anterior approach at C2-3-4.
Study: NCT05560074

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Buzzy
Description: In the Buzzy® group, 30 seconds before the blood collection procedure and during the procedure, the Buzzy® device ist placed 3-5 cm above the area from where the blood would be taken by the PhD qualified nurse researcher

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DistrACTION® Cards
Description: In the DistrACTION® Cards group, picture cards containing various hidden pictures and patterns are used during blood collection by the PhD qualified nurse researcher
Study: NCT05232344

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol / Progesterone
Description: Treatment with estradiol (Provames®, 3 mg morning and evening, or 6 mg per day) will start on the 1st or 2nd day of her period. This treatment is continued until the end of the study (discontinuation treatment after the blood test taken on Day 7). After ten days of minimum estradiol treatment (and up to 7 days later to be working days), vaginal progesterone treatment will start in the evening on Day 0 (400 mg, Progestan®, evening and morning, ie 800 mg per day).
Study: NCT06698744

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Patients will receive 3 days of intravenous (IV) cyclophosphamide 500 mg/m\^2 days -5 to -3 or -4 to -2 where day 0 is the day of CAR T-cell infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Patients will receive 3 days of IV fludarabine 30 mg/m2 days -5 to -3 or -4 to -2 where day 0 is the day of CAR T-cell infusion.
Study: NCT06699121

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB-P8 low-dose
Description: One capsule QD (1×10\^10 CFU/day) oral administration
Study: NCT06506760

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality Therapy
Description: 8 sessions of VR therapy over 4 weeks (each of them 20 minutes long).~As a virtual reality source, VRTierOne device (Stolgraf®) were used. Thanks to using head mounted display and the phenomenon of total immersion VR therapy provides an intense visual, auditory and kinesthetic stimulation. It can have a calming and mood-improving effect or help the patients recognize their psychological resources and motivate to the rehabilitation process. In the virtual therapeutic garden there are a rich set of symbols and metaphors based on Ericksonian Psychotherapy approach. The most important is the Garden of Revival which symbolizes the patient's health. It used to be full of life and energy, now it is neglected, requires work to be revived. In the therapeutic process day by day, the therapist tells the patient a symbolic story about his/her situation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Four weeks of conventional rehabilitation including:~Two hours of kinesiotherapy (120 minutes, including gait training). Thirty minutes of ergotherapy. Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.
Study: NCT05232344

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sexual event
Description: A sexual intercourse (protected or not protected by condoms) will take place in a pre-defined order for each participant within one hour of the administration of the progesterone ovum on the evening of Day 2 and Day 6.
Study: NCT05405855

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eLIFEwithIBD
Description: eLIFEwithIBD program is a psychotherapeutic programme based on Acceptance, Mindfulness and Compassion for inflammatory bowel disease patients.
Study: NCT06102291

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yanqing Zhitong Ointment Acupoint application
Description: Yanqing Zhitong Ointment is a traditional external preparation of experiential prescription, which is an extract made by water extraction and concentration of Qingfengteng, Corydalis yanhusuo, Interleukin, Kansui, Asarum, etc. Clinical studies in the past ten years have preliminarily shown that it has the effects of warming meridians, promoting blood circulation, dredging collaterals and relieving pain, and has a definite effect.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: The main acupoints are Ashi points, Shenshu (BL23), Guanyuanshu (BL26). There are three sessions per week with each session lasting for 20 min. There will be 4 weeks of treatment for each participant in total.
Study: NCT05373186

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Euglycemic clamp with BC Combo THDB0207
Description: Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure
Study: NCT06699121

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB-P8 high-dose
Description: One capsule QD (1×10\^11 CFU/day) oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One capsule QD oral administration
Study: NCT05373186

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Euglycemic clamp with Humalog® Mix25
Description: Administration of a single dose of Humalog® Mix25 during an euglycemic clamp procedure

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Euglycemic clamp with Humalog® and Lantus®
Description: Simultaneous administration of Humalog® and Lantus® during an euglycemic clamp procedure
Study: NCT05257668

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Interval Exercise Training
Description: High Intensity Interval Training Group

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate Intensity Exercise Training
Description: Moderate Intensity Training Group
Study: NCT05791344

Intervention type: DEVICE
Intervention: ECG monitoring
Description: Intra-procedural ECG changes during TAVR
Study: NCT06778785

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalization Algorithm
Description: a proprietary algorithm that adaptively adjust the treatment module and parameters to personalize the treatment regime
Study: NCT06777693

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Unified Protocol
Description: The Unified Protocol group format involves 12 sessions focusing on goal setting and motivation, understanding emotions, mindful emotion awareness, cognitive flexibility, countering emotionat behaviours, understanding and confronting physical sensations, emotion exposure and relapse prevention.~The UP model directly approaches the patient\&#39;s emotion regulation by focusing on cognitive flexibility, exposure exercises, mindful awareness, acceptance, and other evidence-based therapeutic approaches known from cognitive-behavioural therapy (CBT), emotion-focused therapy (EFT) and mindfulness-based interventions.
Study: NCT06116474

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-Based Physical Fitness Intervention
Description: The exercise program has been designed according to the progressive overload method. Therefore, the volume of the exercise program increased as the weeks progressed. Exercise videos were uploaded to YouTube on Mondays, Wednesdays and Fridays send to participants via a message group to follow the program. The videos featured the experts' explanations of the movements for each exercise.. The equipment that the participants should use in the training sessions was selected from the materials available at home (eg., use of water bottles instead of weight dumbbells). The exercise sessions is divided into 3 parts: warm-up (2-4 min. average), main part (14-19 min. average), cool-down (3-5 min. average). The warm-up includes movements to increase the heart rate and warm up the muscles to be worked on for that session. The main part of the exercise program also included rest breaks when the participants were asked to move and stretch.
Study: NCT06065787

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroGlove
Description: The NeuroGlove is intended to provide peripheral sensory stimulation to the hand through pneumatic puffs of air to encourage collateral blood supply and sensorimotor development.
Study: NCT04953780

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase pegol-mknl
Description: Calaspargase pegol-mknl

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase pegol-mknl
Description: Calaspargase pegol-mknl

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase pegol-mknl
Description: Calaspargase pegol-mknl

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase pegol-mknl
Description: Calaspargase pegol-mknl
Study: NCT04778488

Intervention type: DEVICE
Group type: OTHER
Intervention: Near-Infrared-Spectroscopy (NIRS)
Description: Placement of 2 NIRS optodes on the patients' forehead, measurement of NIRS during cardiac arrest and up to 72h post return of spontaneous circulation
Study: NCT06377033

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.
Study: NCT05951673

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe Space based life skills training program
Description: This is a Safe Space based life skills training program given to adolescent girls. Girls receive a 12 month long training on life skills such as negotiation skills, communication skills, sexual and reproductive health, gender-based violence and climate change.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe Space based life skills training program
Description: This is a Safe Space based life skills training program given to adolescent girls. Girls receive a 12 month long training on life skills such as negotiation skills, communication skills, sexual and reproductive health, gender-based violence and climate change.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe Space based life skills training program + Digital Skills
Description: This is a Safe Space based life skills training program given to adolescent girls complemented with a digital literacy training program. Girls receive a 12 month long training on life skills such as negotiation skills, communication skills, sexual and reproductive health, gender-based violence and climate change. The adolescent girls in this group also receive a digital literacy training program that covers content on word processing. database management and analysis, online marketing, online safety and programming.
Study: NCT06043440

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: Active nocturnal oxygen concentrator
Study: NCT00845689

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: NaCl 0,9 %

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: adenosine
Description: intravenous infusion of adenosine 0, 2 %

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: adenosine
Description: intravenous infusion of adenosine 0,2 %

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Liver resection
Description: Liver resection with Pringle maneuver
Study: NCT06699368

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: The ultra-high-power ablation group
Description: The ultra-high-power ablation group will use the QDOT ablation catheter with a power of 90W, ablation points at site 3, inter-point distance maintained at 4-5mm, pressure maintained at 5-30g. The cold saline flow rate during ablation is 8ml/min, and the ablation device will adjust power and saline flow rate based on the electrode temperature at the tip of the QDOT ablation catheter. The target temperature is 60°C, and the cut-off temperature is 65°C, with an ablation endpoint of 4 seconds.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The high-power ablation group
Description: The high-power ablation group will use the STSF ablation catheter with a power of 50W, ablation points at site 3, inter-point distance maintained at 4-5mm, pressure maintained at 5-30g, and a cold saline flow rate of 15ml/min during ablation. The ablation endpoint for the posterior wall of the left atrium is an Ablation Index (AI) value of 360-410, for the anterior wall 450-480, and for the bottom and top of the left atrium 420-450.
Study: NCT00845689

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Liver resection
Description: Liver resection with Pringle maneuver

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Liver resection
Description: Liver resection with Pringle maneuver
Study: NCT05035550

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-Deceptive Placebo
Description: The placebos were ordered through Amazon from Zeebo® (Zeebo, Zeebo Effect, LLC, South Burlington, Vermont, USA). The placebos in this study were blue and white capsules containing Microcrystalline cellulose (an inert fiber). Ingredients include ones that are typically used to make pills including silica, gelatin, titanium dioxide, red #3 food coloring, and blue #1 food coloring. Placebo capsules were free of any active ingredients. These bottles were not branded specifically for the experiment, including the brand name (Zeebo Relief), description of the contents, directions, and a disclaimer. The investigators chose to not include a custom label for transparency and in order to increase non-deceptive placebo effects. Participants were instructed to take two pills a day, one in the morning and one in the evening.
Study: NCT05741320

Intervention type: OTHER
Intervention: questionnaire
Description: 27 questions will be asked to public to find out what is the role of anesthetists after the covıd pandemic
Study: NCT06698510

Intervention type: DRUG
Intervention: Arpraziquantel 150mg dispersible tablet
Description: Arpraziquantel 150mg dispersible tablets given as single oral dose of 50mg/kg (in Kenya and Uganda; for Schistosoma mansoni infection) or 60mg/kg (in Côte d'Ivoire; for mixed infections with S. mansoni / S. haematobium) using weight-based dosing tables as detailed in the summary of product characteristics.

Intervention type: DRUG
Intervention: Arpraziquantel 150mg dispersible tablet
Description: Arpraziquantel 150mg dispersible tablets given as single oral dose of 50mg/kg (in Kenya and Uganda; for Schistosoma mansoni infection) or 60mg/kg (in Côte d'Ivoire; for mixed infections with S. mansoni / S. haematobium) using weight-based dosing tables as detailed in the summary of product characteristics.
Study: NCT06699888

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cervicothoracic manipulation group
Description: The participant lay prone with the head firmly into the head piece Palpation of the upper cervico-thoracic segment observed the side of the restriction.~The participants head was rotated to the contralateral side of the restriction. The practitioner's hand contacted the forehead and the other hand's thumb contacted the spinous process of the restricted side.~A low amplitude, high velocity thrust towards the axilla was applied, on the spinous process in PA direction.~Experimental group also received following exercises Chin tuck Strengthening Shoulder Retractors. Stretching SCM Pectoralis Stretch 3 × 10 repetitions, 3 times a week for 2 weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: forward head correction exercises traditional group
Description: Chin tuck Strengthening Shoulder Retractors. Stretching SCM Pectoralis Stretch 3 × 10 repetitions, 3 times a week for 2 weeks.
Study: NCT06700278

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: acupressure
Description: Acupoint massage was performed three times daily, with each acupoint massaged for three minutes at an optimal pressure level that induced sensations of soreness, numbness, distension, or mild pain. This was conducted five days a week for three weeks, in addition to regular rehabilitation therapy provided five days per week.
Study: NCT04740775

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiquiBand Exceed
Description: Cyanoacrylate glue for closure of surgical wounds

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiquiBand Rapid
Description: Cyanoacrylate glue for closure of surgical wounds
Study: NCT05104697

Intervention type: DEVICE
Group type: OTHER
Intervention: Transcranial Magnetic Stimulation
Description: All teens will receive active TMS; they will be randomly assigned to receive active TMS at either visit 1 or visit 2 (order counterbalanced)

Intervention type: DEVICE
Group type: OTHER
Intervention: Transcranial Magnetic Stimulation
Description: All teens will receive active TMS; they will be randomly assigned to receive active TMS at either visit 1 or visit 2 (order counterbalanced)